Antibiotic Pressure and Nosocomial Disease

Murtaugh, Robert J.; Mason, G. D.

doi:10.1016/s0195-5616(89)50138-4

Cited by 12 publications

(3 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Even in veterinary medicine the development of strict policies to prevent nosocomial infections (defined as those acquired in animal holding or treatment facilities) and to define antibiotic usage has been suggested Data from: 'Jones (1986), 2Wiegersma et al (1982. Table 4 Effects of antibiotics on host microflora and colonization resistance (Murtaugh &. Mason 1989).…”

Section: Lack Of Adequate Bacteriological Information (Eg Sensitivimentioning

confidence: 99%

Antibiotic therapeutics in laboratory animals

Morris

1995

Lab Anim

View full text Add to dashboard Cite

SummaryInformation on antibiotic therapeutics in laboratory species, especially in rodents and rabbits, is reviewed. A number of areas are considered: interference by antibiotics with an experiment, antibiotic toxicity, routes of administration, effects of formulation on bioavailability, antibiotic prophylaxis, use of combinations of antibiotics, misuse of antibiotics, regulatory approval for antibiotic use in animals, sources of information on antibiotic indications and dose, and extrapolation of dose information from other species.

show abstract

Section: Lack Of Adequate Bacteriological Information (Eg Sensitivimentioning

confidence: 99%

Antibiotic therapeutics in laboratory animals

Morris

1995

Lab Anim

View full text Add to dashboard Cite

show abstract

“…This finding is consistent with the well-known increasing rate of nosocomial obtained MDR organisms in both human and veterinary medicine. [54][55][56] This high proportion of antimicrobial resistance in both companion animals as well as people highlights the need for a targeted nonantimicrobial therapy for the treatment of urinary tract infections.…”

Section: Discussionmentioning

confidence: 99%

Escherichia coli probiotic exhibits in vitro growth-limiting effects on clinical feline uropathogenic E coli isolates

Snell

Winston

Quimby

et al. 2022

ajvr

View full text Add to dashboard Cite

OBJECTIVE To characterize uropathogenic Escherichia coli (UPEC) in cases of clinical feline urinary tract infection (UTI) and subclinical bacteriuria and investigate the in vitro effects of E coli strain Nissle 1917 on isolate growth. ANIMALS 40 cats with positive E coli culture results for urine collected during routine evaluation. PROCEDURES Characterization of UPEC isolates was performed by PCR-based phylotype analysis and serotyping. Nissle 1917 effects on growth inhibition and competitive overgrowth against UPEC isolates were evaluated in vitro using a plate-based competition assay. RESULTS Feline phylogroups were similar to previous human and feline UPEC studies, with most of the isolates belonging to phylogroup A (42.5%), B2 (37.5%), and D (15.0%). Fifty-two percent of isolates were found to be resistant to antimicrobials, with 19% of these being multidrug resistant (MDR). Nissle 1917 adversely affected the growth of 82.5% of all isolates and 100% of MDR isolates in vitro. The median zone of inhibition was 3.33 mm (range, 1.67 to 10.67 mm). Thirteen isolates were affected via competitive overgrowth and 20 via growth inhibition. CLINICAL RELEVANCE UPEC isolates from cats were similar in phylogroup analysis to human and dog isolates. The in vitro effects of Nissle 1917 on UPEC warrant additional studies to determine if similar results can be duplicated in vivo.

show abstract

“…In 1989 Murtaugh and Mason proposed that nosocomial infection control committees be established in veterinary hospitals, especially at the larger teaching and referral centers. 37 Some veterinary institutions were receptive to this proposal, but there are still no national or international standards for veterinary hospital infection control. A survey of veterinary teaching hospitals in the United States indicated that only 42% of these hospitals required personnel to complete a biosecurity training program, but 40% of respondents indicated that they believed that their hospital ranked…”

Section: Nosocomial Infection Prevention and Controlmentioning

confidence: 99%

Nosocomial Infections and Zoonoses

Rankin¹

2015

Small Animal Critical Care Medicine

View full text Add to dashboard Cite

Antibiotic Pressure and Nosocomial Disease

Cited by 12 publications

References 22 publications

Antibiotic therapeutics in laboratory animals

Antibiotic therapeutics in laboratory animals

Escherichia coli probiotic exhibits in vitro growth-limiting effects on clinical feline uropathogenic E coli isolates

Nosocomial Infections and Zoonoses

Contact Info

Product

Resources

About